<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01828255</url>
  </required_header>
  <id_info>
    <org_study_id>TF-1212</org_study_id>
    <nct_id>NCT01828255</nct_id>
  </id_info>
  <brief_title>Intraocular Pressure (IOP) Patterns in Fast Versus Slow Visual Field (VF) Progression Patients</brief_title>
  <official_title>A Single Center, Case-control, Open Label Study Assessing Intraocular Pressure Patterns in Patients With Primary Open-angle Glaucoma Experiencing Fast Versus Slow Visual Field Progression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sensimed AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sensimed AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate how the intraocular pressure (IOP) varies in time&#xD;
      and if the IOP variations are associated with the worsening of glaucoma. IOP patterns will be&#xD;
      recorded continuously over 24 hours with SENSIMED Triggerfish速 (TF) a portable&#xD;
      investigational device using a contact lens sensor. After completing the Triggerfish lens&#xD;
      placement and removal; the patient will complete a formal Polysomnography.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Low recruitment rate&#xD;
  </why_stopped>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Relationship Between 24-hour IOP Pattern as Recorded by TF and VF Progression in Patients With POAG.</measure>
    <time_frame>24-hour</time_frame>
    <description>24-hour measurement of TF, corresponding to IOP-related fluctuations expressed in arbitrary units of mini volts equivalent (mVeq) and comparison of this measurement between POAG patients showing fast and slow rates of glaucoma visual field progression.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Relationship Between TF Pattern and VF Progression According to TF Slope</measure>
    <time_frame>24-hour</time_frame>
    <description>Measurement of TF, corresponding to IOP-related fluctuations expressed in arbitrary units of mini volts equivalent (mVeq) and comparison of this measurement between POAG patients showing fast and slow rates of glaucoma visual field progression during wake vs sleep periods. The wake slope corresponds to the change in the TF signal from 1 hour before to 1 hour after the time the subject went to sleep. The sleep slope corresponds to the change from 1 hour before to 1 hour after the time the subject awoke.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship Between TF Pattern and VF Progression According to Day and Night</measure>
    <time_frame>24-hour</time_frame>
    <description>TF measurement during diurnal and nocturnal periods and comparison of this measurement between POAG patients showing fast and slow rates of glaucoma visual field progression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship Between 24-hour TF Pattern and VF Progression According to TF Peak</measure>
    <time_frame>24-hour</time_frame>
    <description>Number of peaks in 24-Hours TF pattern, defined as the local maximum point in the smoothed TF profile.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24-hour TF IOP Pattern in Patients With POAG With Fast and Slow Rates of VF Progression</measure>
    <time_frame>24-hour</time_frame>
    <description>Comparison (Spearman correlations) between 24-hour IOP-related fluctuations measured by TF and 24-hour blood pressure profiles (systolic, diastolic and mean arterial blood pressure) of POAG patients showing fast and slow rates of glaucoma visual field progression. The correlation between TF and blood pressure measurement was calculated within each subject then mean values were obtained for patients with slow vs fast glaucoma visual field progression.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Primary Open-angle Glaucoma (POAG) Patient</condition>
  <arm_group>
    <arm_group_label>SENSIMED Triggerfish速</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device: portable device that monitors the 24-hour IOP pattern by a wireless contact lens sensor placed on the eye that sends its signals via an antenna around the orbital cavity to a recorder. Upon completion, the recording can be transmitted to a computer for read-out and visualization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SENSIMED Triggerfish速</intervention_name>
    <arm_group_label>SENSIMED Triggerfish速</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 40 and 89 years old&#xD;
&#xD;
          -  Diagnosis of treated POAG (including normal tension glaucoma (NTG))&#xD;
&#xD;
          -  All IOP measurements during the VF period (to be described further) equal or lower&#xD;
             than 18 mmHg and/or on average equal or lower than 16 mmHg in the same period&#xD;
&#xD;
          -  Documented glaucomatous VF damage at baseline, characterized by glaucoma hemifield&#xD;
             test result outside normal limits on at least 2 consecutive VF tests or the presence&#xD;
             of at least 3 contiguous test points within the same hemifield on the pattern&#xD;
             deviation plot at p&lt;0.01, with at least 1 point at p &lt; 0.005&#xD;
&#xD;
          -  At least 8 visual field tests carried out within at least 2 years, all with fixation&#xD;
             losses and false positive/negative results equal or less than 33%&#xD;
&#xD;
          -  For fast progressing eyes, 1) pointwise progression defined as two or more adjacent VF&#xD;
             test locations in the same hemifield that show a threshold sensitivity rate of change&#xD;
             more negative than -1.0 dB/year with p&lt;0.01 or 2) a global rate of VF change based on&#xD;
             mean deviation (MD) more negative than -1.0 dB/year&#xD;
&#xD;
          -  For slowly or minimally progressing eyes a VF MD rate of change more positive than&#xD;
             -0.5 dB/year with no significant pointwise progression as described above&#xD;
&#xD;
          -  Not more than 6 diopters spherical equivalent on the study eye&#xD;
&#xD;
          -  Have given written informed consent, prior to any investigational procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Baseline VF MD more negative than -15 dB. The rationale here is that in severely&#xD;
             damaged visual fields, one may not be able to detect and measure rates of progression&#xD;
             due to a 'floor effect'&#xD;
&#xD;
          -  Corneal or conjunctival abnormality precluding contact lens adaptation&#xD;
&#xD;
          -  Severe dry eye syndrome or other ocular disease&#xD;
&#xD;
          -  Patients with angle closure glaucoma, traumatic glaucoma or uveitic glaucoma&#xD;
&#xD;
          -  Patients with previous intraocular surgery in the enrolled eye, including cataract&#xD;
             surgery&#xD;
&#xD;
          -  Patients with allergy to corneal anesthetic&#xD;
&#xD;
          -  Patients with contraindications for silicone contact lens wear&#xD;
&#xD;
          -  Patients not able to understand the character and individual consequences of the&#xD;
             investigation&#xD;
&#xD;
          -  Participation in unrelated clinical research within the last 4 weeks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gustavo De Moraes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The New York Eye and Ear Infirmary</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeffrey M Liebmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The New York Eye and Ear Infirmary</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Ritch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The New York Eye and Ear Infirmary</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The New York Eye and Ear Infirmary</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>April 5, 2013</study_first_submitted>
  <study_first_submitted_qc>April 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2013</study_first_posted>
  <results_first_submitted>November 17, 2015</results_first_submitted>
  <results_first_submitted_qc>September 15, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 9, 2020</results_first_posted>
  <last_update_submitted>September 15, 2020</last_update_submitted>
  <last_update_submitted_qc>September 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Fast Progressors</title>
          <description>pointwise progression defined as two or more adjacent VF test locations in the same hemifield that show a threshold sensitivity rate of change more negative than -1.0 dB/year with p&lt;0.01 or a global rate of VF change based on MD more negative than -1.0 dB/year</description>
        </group>
        <group group_id="P2">
          <title>Slow Progressors</title>
          <description>VF MD rate of change more positive than -0.5 dB/year with no significant point defined as two or more adjacent VF test locations in the same hemifield that show a threshold sensitivity rate of change more negative than -1.0 dB/year with p&lt;0.01wise progression</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Slow Progressors</title>
          <description>VF MD rate of change more positive than -0.5 dB/year with no significant pointwise progression defined as two or more adjacent VF test locations in the same hemifield</description>
        </group>
        <group group_id="B2">
          <title>Fast Progressors</title>
          <description>pointwise progression defined as two or more adjacent VF test locations in the same hemifield that show a threshold sensitivity rate of change more negative than -1.0 dB/year with p&lt;0.01 or a global rate of VF change based on MD more negative than -1.0 dB/year</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.4" spread="8.3"/>
                    <measurement group_id="B2" value="68.3" spread="8.6"/>
                    <measurement group_id="B3" value="67" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Visual field defect</title>
          <description>Visual field is measured by perimetry and the mean defect (MD) is assesses the defect in the visual field.</description>
          <units>dB</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="-0.07" spread="0.12"/>
                    <measurement group_id="B2" value="-1.88" spread="0.48"/>
                    <measurement group_id="B3" value="-0.98" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Relationship Between 24-hour IOP Pattern as Recorded by TF and VF Progression in Patients With POAG.</title>
        <description>24-hour measurement of TF, corresponding to IOP-related fluctuations expressed in arbitrary units of mini volts equivalent (mVeq) and comparison of this measurement between POAG patients showing fast and slow rates of glaucoma visual field progression.</description>
        <time_frame>24-hour</time_frame>
        <population>POAG patients with slow or fast rate of VF glaucoma progression</population>
        <group_list>
          <group group_id="O1">
            <title>Fast Progressors</title>
            <description>Patients with a fast rate of progression (&lt;-1dB/y)</description>
          </group>
          <group group_id="O2">
            <title>Slow Progressors</title>
            <description>Patients with a slow rate of progression (&gt;-1dB/y)</description>
          </group>
        </group_list>
        <measure>
          <title>Relationship Between 24-hour IOP Pattern as Recorded by TF and VF Progression in Patients With POAG.</title>
          <description>24-hour measurement of TF, corresponding to IOP-related fluctuations expressed in arbitrary units of mini volts equivalent (mVeq) and comparison of this measurement between POAG patients showing fast and slow rates of glaucoma visual field progression.</description>
          <population>POAG patients with slow or fast rate of VF glaucoma progression</population>
          <units>mVeq</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="410.1" spread="138.4"/>
                    <measurement group_id="O2" value="334.6" spread="119.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Relationship Between TF Pattern and VF Progression According to TF Slope</title>
        <description>Measurement of TF, corresponding to IOP-related fluctuations expressed in arbitrary units of mini volts equivalent (mVeq) and comparison of this measurement between POAG patients showing fast and slow rates of glaucoma visual field progression during wake vs sleep periods. The wake slope corresponds to the change in the TF signal from 1 hour before to 1 hour after the time the subject went to sleep. The sleep slope corresponds to the change from 1 hour before to 1 hour after the time the subject awoke.</description>
        <time_frame>24-hour</time_frame>
        <population>POAG patients with slow or fast rate of VF glaucoma progression</population>
        <group_list>
          <group group_id="O1">
            <title>Fast</title>
            <description>Pointwise progression defined as two or more adjacent VF test locations in the same hemifield that show a threshold sensitivity rate of change more negative than -1.0 dB/year with p&lt;0.01 or a global rate of VF change based on MD more negative than -1.0 dB/year</description>
          </group>
          <group group_id="O2">
            <title>Slow</title>
            <description>VF MD rate of change more positive than -0.5 dB/year with no significant pointwise progression defined as two or more adjacent VF test locations in the same hemifield</description>
          </group>
        </group_list>
        <measure>
          <title>Relationship Between TF Pattern and VF Progression According to TF Slope</title>
          <description>Measurement of TF, corresponding to IOP-related fluctuations expressed in arbitrary units of mini volts equivalent (mVeq) and comparison of this measurement between POAG patients showing fast and slow rates of glaucoma visual field progression during wake vs sleep periods. The wake slope corresponds to the change in the TF signal from 1 hour before to 1 hour after the time the subject went to sleep. The sleep slope corresponds to the change from 1 hour before to 1 hour after the time the subject awoke.</description>
          <population>POAG patients with slow or fast rate of VF glaucoma progression</population>
          <units>mVeq/hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Wake slope</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.9" spread="55.7"/>
                    <measurement group_id="O2" value="34.6" spread="44.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sleep slope</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-33.5" spread="44.6"/>
                    <measurement group_id="O2" value="-35.7" spread="61.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Relationship Between TF Pattern and VF Progression According to Day and Night</title>
        <description>TF measurement during diurnal and nocturnal periods and comparison of this measurement between POAG patients showing fast and slow rates of glaucoma visual field progression.</description>
        <time_frame>24-hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fast</title>
            <description>Pointwise progression defined as two or more adjacent VF test locations in the same hemifield that show a threshold sensitivity rate of change more negative than -1.0 dB/year with p&lt;0.01 or a global rate of VF change based on MD more negative than -1.0 dB/year</description>
          </group>
          <group group_id="O2">
            <title>Slow</title>
            <description>VF MD rate of change more positive than -0.5 dB/year with no significant pointwise progression defined as two or more adjacent VF test locations in the same hemifield</description>
          </group>
        </group_list>
        <measure>
          <title>Relationship Between TF Pattern and VF Progression According to Day and Night</title>
          <description>TF measurement during diurnal and nocturnal periods and comparison of this measurement between POAG patients showing fast and slow rates of glaucoma visual field progression.</description>
          <units>mVeq</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Diurnal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.0" spread="37.2"/>
                    <measurement group_id="O2" value="93.9" spread="40.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nocturnal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.8" spread="9.6"/>
                    <measurement group_id="O2" value="42.3" spread="16.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Relationship Between 24-hour TF Pattern and VF Progression According to TF Peak</title>
        <description>Number of peaks in 24-Hours TF pattern, defined as the local maximum point in the smoothed TF profile.</description>
        <time_frame>24-hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fast</title>
            <description>Pointwise progression defined as two or more adjacent VF test locations in the same hemifield that show a threshold sensitivity rate of change more negative than -1.0 dB/year with p&lt;0.01 or a global rate of VF change based on MD more negative than -1.0 dB/year</description>
          </group>
          <group group_id="O2">
            <title>Slow</title>
            <description>VF MD rate of change more positive than -0.5 dB/year with no significant pointwise progression defined as two or more adjacent VF test locations in the same hemifield</description>
          </group>
        </group_list>
        <measure>
          <title>Relationship Between 24-hour TF Pattern and VF Progression According to TF Peak</title>
          <description>Number of peaks in 24-Hours TF pattern, defined as the local maximum point in the smoothed TF profile.</description>
          <units>Number of peaks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.1" spread="3.0"/>
                    <measurement group_id="O2" value="14.1" spread="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.005</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>24-hour TF IOP Pattern in Patients With POAG With Fast and Slow Rates of VF Progression</title>
        <description>Comparison (Spearman correlations) between 24-hour IOP-related fluctuations measured by TF and 24-hour blood pressure profiles (systolic, diastolic and mean arterial blood pressure) of POAG patients showing fast and slow rates of glaucoma visual field progression. The correlation between TF and blood pressure measurement was calculated within each subject then mean values were obtained for patients with slow vs fast glaucoma visual field progression.</description>
        <time_frame>24-hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fast</title>
            <description>Pointwise progression defined as two or more adjacent VF test locations in the same hemifield that show a threshold sensitivity rate of change more negative than -1.0 dB/year with p&lt;0.01 or a global rate of VF change based on MD more negative than -1.0 dB/year</description>
          </group>
          <group group_id="O2">
            <title>Slow</title>
            <description>VF MD rate of change more positive than -0.5 dB/year with no significant pointwise progression defined as two or more adjacent VF test locations in the same hemifield</description>
          </group>
        </group_list>
        <measure>
          <title>24-hour TF IOP Pattern in Patients With POAG With Fast and Slow Rates of VF Progression</title>
          <description>Comparison (Spearman correlations) between 24-hour IOP-related fluctuations measured by TF and 24-hour blood pressure profiles (systolic, diastolic and mean arterial blood pressure) of POAG patients showing fast and slow rates of glaucoma visual field progression. The correlation between TF and blood pressure measurement was calculated within each subject then mean values were obtained for patients with slow vs fast glaucoma visual field progression.</description>
          <units>coefficient of correlation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Systolic blood pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08" spread="0.32"/>
                    <measurement group_id="O2" value="-0.19" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic blood pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="0.36"/>
                    <measurement group_id="O2" value="-0.22" spread="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean arterial blood pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="0.35"/>
                    <measurement group_id="O2" value="-0.21" spread="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Fast Progressors</title>
          <description>Pointwise progression defined as two or more adjacent VF test locations in the same hemifield that show a threshold sensitivity rate of change more negative than -1.0 dB/year with p&lt;0.01 or a global rate of VF change based on MD more negative than -1.0 dB/year</description>
        </group>
        <group group_id="E2">
          <title>Slow Progressors</title>
          <description>VF MD rate of change more positive than -0.5 dB/year with no significant pointwise progression defined as two or more adjacent VF test locations in the same hemifield</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Corneal abrasion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Gustavo De Moraes</name_or_title>
      <organization>The New York Eye and Ear Infirmary</organization>
      <phone>+1 212 477 7540</phone>
      <email>demoraesmd@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

